PubRank

E A Musgrove

Author PubWeight™ 62.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983 9.40
2 Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993 3.79
3 Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 1997 2.40
4 Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr Relat Cancer 2003 2.06
5 c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol Cell Biol 1998 1.97
6 Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. Clin Cancer Res 1999 1.65
7 Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation. Cancer Res 1988 1.47
8 The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Ann Oncol 2012 1.46
9 Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol Endocrinol 1995 1.35
10 A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence. J Biol Chem 2000 1.34
11 Estrogen and progestin regulation of cell cycle progression. J Mammary Gland Biol Neoplasia 1998 1.26
12 INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. Clin Cancer Res 2000 1.26
13 Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome. Oncogene 2009 1.15
14 Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells. Oncogene 1998 1.15
15 Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity. Mol Pharmacol 2001 1.13
16 The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycle. J Physiol 2000 1.09
17 The influence of age on the DNA ploidy levels of breast tumours. Eur J Cancer Clin Oncol 1983 1.09
18 EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene 1997 1.08
19 Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast Cancer Res Treat 1994 1.07
20 Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens. Clin Cancer Res 1997 1.06
21 EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival. Oncogene 1998 1.05
22 Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells. Oncogene 1998 1.04
23 Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clin Cancer Res 1996 1.04
24 Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells. Int J Cancer 1997 1.03
25 Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells. Oncogene 1997 0.95
26 Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells. Mol Cell Biol 2000 0.95
27 Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer Res 1988 0.95
28 Retinoic acid-mediated growth arrest requires ubiquitylation and degradation of the F-box protein Skp2. J Biol Chem 2001 0.92
29 BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast. Br J Cancer 2008 0.92
30 Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation. Oncogene 2007 0.91
31 Ploidy as a prognostic factor in ovarian cancer. Int J Gynecol Pathol 1983 0.90
32 Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cells. Oncogene 1995 0.90
33 Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin. Cancer Res 1989 0.89
34 Expression and regulation of cyclin genes in breast cancer. Acta Oncol 1995 0.88
35 Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma. Br J Cancer 2008 0.88
36 Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer. Oncogene 2011 0.85
37 The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5. Mol Endocrinol 2010 0.83
38 Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. Cell Growth Differ 1996 0.83
39 Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells. J Cell Physiol 1989 0.83
40 Cyclin gene expression and growth control in normal and neoplastic human breast epithelium. J Steroid Biochem Mol Biol 1993 0.82
41 Immunofluorescent quantification of ribonucleotide reductase M1 subunit and correlation with DNA content by flow cytometry. Cytometry 1987 0.82
42 Transferrin receptor cycling by human lymphoid cells: lack of effect from inhibition of microtubule assembly. Biochem Biophys Res Commun 1986 0.82
43 Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines. Cancer Res 1990 0.81
44 Steroids, growth factors, and cell cycle controls in breast cancer. Cancer Treat Res 1991 0.79
45 Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonists. J Steroid Biochem Mol Biol 1992 0.79
46 Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells. Br J Cancer 2013 0.77
47 Different points of action of retinoids and anti-estrogens in G1 phase identified in synchronized T-47D breast cancer cells. Int J Cancer 1997 0.77
48 DNA flow cytometry of paraffin-embedded tissue. Cytometry 1984 0.77
49 Cyclins and breast cancer. Cancer Treat Res 1996 0.75
50 Flow cytometric enumeration of drug-resistant tumor cells. Cancer Res 1988 0.75
51 Enumeration of 6-thioguanine-resistant tumour cells using flow cytometry and comparison with a microtitration cloning assay. Mutat Res 1989 0.75
52 Steroidal regulation of cell cycle progression. Ciba Found Symp 1995 0.75